Found: 24
Select item for more details and to access through your institution.
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 860, doi. 10.1111/ejh.14181
- By:
- Publication type:
- Article
Teclistamab‐cqyv in multiple myeloma.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 320, doi. 10.1111/ejh.14121
- By:
- Publication type:
- Article
Iron chelation therapy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 5, p. 490, doi. 10.1111/ejh.13935
- By:
- Publication type:
- Article
Diplopia and hemianopsia as initial manifestations of multicentric Castleman disease successfully treated with siltuximab.
- Published in:
- Current Therapeutics, 2022, v. 25, n. 5, p. 20
- By:
- Publication type:
- Article
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.643490
- By:
- Publication type:
- Article
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.599502
- By:
- Publication type:
- Article
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00967
- By:
- Publication type:
- Article
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 2969, doi. 10.2147/DDDT.S295215
- By:
- Publication type:
- Article
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4970, doi. 10.3390/curroncol29070395
- By:
- Publication type:
- Article
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Wave Polarization Control in Anisotropic Locally Resonant Materials.
- Published in:
- Applied Sciences (2076-3417), 2023, v. 13, n. 19, p. 10797, doi. 10.3390/app131910797
- By:
- Publication type:
- Article
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Bendamustine in multiple myeloma.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 5, p. 377, doi. 10.1111/ejh.12609
- By:
- Publication type:
- Article
Chemotherapy-based regimens in multiple myeloma in 2020.
- Published in:
- Panminerva Medica, 2021, v. 63, n. 1, p. 7, doi. 10.23736/S0031-0808.20.04145-2
- By:
- Publication type:
- Article
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01186
- By:
- Publication type:
- Article
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890376
- By:
- Publication type:
- Article
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3706, doi. 10.3390/cancers15143706
- By:
- Publication type:
- Article
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3213, doi. 10.3390/cancers13133213
- By:
- Publication type:
- Article
Tagraxofusp in myeloid malignancies.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3234
- By:
- Publication type:
- Article
Myelodysplastic syndromes with ring sideroblasts.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 612, doi. 10.1002/hon.3125
- By:
- Publication type:
- Article
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1009, doi. 10.1002/hon.3035
- By:
- Publication type:
- Article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article